Diabetes, Vol 44, Issue 7 767-774, Copyright © 1995 by American Diabetes Association

ARTICLES

Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization

J Gromada, S Dissing, K Bokvist, E Renstrom, J Frokjaer-Jensen, BS Wulff and P Rorsman
Department of Medical Physiology, Panum Institute, University of Copenhagen, Denmark.

In the insulin-secreting beta-cell line beta TC3, stimulation with 11.2 mmol/l glucose caused a rise in the intracellular free Ca2+ concentration ([Ca2+]i) in only 18% of the tested cells. The number of glucose-responsive cells increased after pretreatment of the cells with glucagon-like peptide I (GLP-I)(7-36)amide and at 10(-11) mol/l; 84% of the cells responded to glucose with a rise in [Ca2+]i. GLP-I(7-36)amide induces a rapid increase in [Ca2+]i only in cells exposed to elevated glucose concentrations (> or = 5.6 mmol/l). The action of GLP-I(7-36)amide and forskolin involved a 10-fold increase in cytoplasmic cAMP concentration and was mediated by activation of protein kinase A. It was not associated with an effect on the membrane potential but required some (small) initial entry of Ca2+ through voltage-dependent L-type Ca2+ channels, which then produced a further increase in [Ca2+]i by mobilization from intracellular stores. The latter effect reflected Ca(2+)-induced Ca2+ release and was blocked by ryanodine. Similar increases in [Ca2+]i were also observed in voltage-clamped cells, although there was neither activation of a background (Ca(2+)-permeable) inward current nor enhancement of the voltage-dependent L-type Ca2+ current. These observations are consistent with GLP-I(7-36) amide inducing glucose sensitivity by promoting mobilization of Ca2+ from intracellular stores. We propose that this novel action of GLP-I(7-36)amide represents an important factor contributing to its insulinotropic action.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. P. Kwan, L. Xie, L. Sheu, T. Ohtsuka, and H. Y. Gaisano Interaction Between Munc13-1 and RIM Is Critical for Glucagon-Like Peptide-1 Mediated Rescue of Exocytotic Defects in Munc13-1 Deficient Pancreatic {beta}-Cells Diabetes, October 1, 2007; 56(10): 2579 - 2588. [Abstract] [Full Text] [PDF]

				J. de Heer and J. J. Holst Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1 Diabetes, February 1, 2007; 56(2): 438 - 443. [Abstract] [Full Text] [PDF]

				Y. Suzuki, H. Zhang, N. Saito, I. Kojima, T. Urano, and H. Mogami Glucagon-like Peptide 1 Activates Protein Kinase C through Ca2+-dependent Activation of Phospholipase C in Insulin-secreting Cells J. Biol. Chem., September 29, 2006; 281(39): 28499 - 28507. [Abstract] [Full Text] [PDF]

				S. Seino and T. Shibasaki PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis Physiol Rev, October 1, 2005; 85(4): 1303 - 1342. [Abstract] [Full Text] [PDF]

				G. Kang, O. G Chepurny, M. J Rindler, L. Collis, Z. Chepurny, W.-h. Li, M. Harbeck, M. W Roe, and G. G Holz A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic {beta} cells J. Physiol., July 1, 2005; 566(1): 173 - 188. [Abstract] [Full Text] [PDF]

				M. A. Nauck, B. Baller, and J. J. Meier Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes Diabetes, December 1, 2004; 53(suppl_3): S190 - S196. [Abstract] [Full Text] [PDF]

				J. J. Holst and J. Gromada Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E199 - E206. [Abstract] [Full Text] [PDF]

				G. G. Holz Epac: A New cAMP-Binding Protein in Support of Glucagon-Like Peptide-1 Receptor-Mediated Signal Transduction in the Pancreatic {beta}-Cell Diabetes, January 1, 2004; 53(1): 5 - 13. [Abstract] [Full Text] [PDF]

				Y. Miura and H. Matsui Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1001 - E1009. [Abstract] [Full Text] [PDF]

				P. E. MacDonald, W. El-kholy, M. J. Riedel, A. M. F. Salapatek, P. E. Light, and M. B. Wheeler The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion Diabetes, December 1, 2002; 51(90003): S434 - 442. [Abstract] [Full Text] [PDF]

				P. E. Light, J. E. Manning Fox, M. J. Riedel, and M. B. Wheeler Glucagon-Like Peptide-1 Inhibits Pancreatic ATP-Sensitive Potassium Channels via a Protein Kinase A- and ADP-Dependent Mechanism Mol. Endocrinol., September 1, 2002; 16(9): 2135 - 2144. [Abstract] [Full Text] [PDF]

				M. S. Islam The Ryanodine Receptor Calcium Channel of {beta}-Cells: Molecular Regulation and Physiological Significance Diabetes, May 1, 2002; 51(5): 1299 - 1309. [Abstract] [Full Text] [PDF]

				M. C. Lawrence, H. S. Bhatt, and R. A. Easom NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1 Diabetes, March 1, 2002; 51(3): 691 - 698. [Abstract] [Full Text] [PDF]

				L. B. Lester, M. C. Faux, J. B. Nauert, and J. D. Scott Targeted Protein Kinase A and PP-2B Regulate Insulin Secretion through Reversible Phosphorylation Endocrinology, March 1, 2001; 142(3): 1218 - 1227. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				H.-P. Bode, B. Moormann, R. Dabew, and B. Göke Glucagon-Like Peptide 1 Elevates Cytosolic Calcium in Pancreatic {beta}-Cells Independently of Protein Kinase A Endocrinology, September 1, 1999; 140(9): 3919 - 3927. [Abstract] [Full Text]

				G. G. Holz, C. A. Leech, R. S. Heller, M. Castonguay, and J. F. Habener cAMP-dependent Mobilization of Intracellular Ca2+ Stores by Activation of Ryanodine Receptors in Pancreatic beta -Cells. A Ca2+ SIGNALING SYSTEM STIMULATED BY THE INSULINOTROPIC HORMONE GLUCAGON-LIKE PEPTIDE-1-(7-37) J. Biol. Chem., May 14, 1999; 274(20): 14147 - 14156. [Abstract] [Full Text] [PDF]

				L. H. Hansen, J. Gromada, P. Bouchelouche, T. Whitmore, L. Jelinek, W. Kindsvogel, and E. Nishimura Glucagon-mediated Ca2+ signaling in BHK cells expressing cloned human glucagon receptors Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1552 - C1562. [Abstract] [Full Text] [PDF]

				M. S. Islam, I. Leibiger, B. Leibiger, D. Rossi, V. Sorrentino, T. J. Ekstrom, H. Westerblad, F. H. Andrade, and P.-O. Berggren In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation PNAS, May 26, 1998; 95(11): 6145 - 6150. [Abstract] [Full Text] [PDF]

				C. A. Leech and J. F. Habener Insulinotropic Glucagon-like Peptide-1-mediated Activation of Non-selective Cation Currents in Insulinoma Cells Is Mimicked by Maitotoxin J. Biol. Chem., July 18, 1997; 272(29): 17987 - 17993. [Abstract] [Full Text] [PDF]

				M. Wm. Roe, J. F. Worley III, A. A. Mittal, A. Kuznetsov, S. DasGupta, R. J. Mertz, S. M. Witherspoon III, N. Blair, M. E. Lancaster, M. S. McIntyre, et al. Expression and Function of Pancreatic beta -Cell Delayed Rectifier K+ Channels. ROLE IN STIMULUS-SECRETION COUPLING J. Biol. Chem., December 13, 1996; 271(50): 32241 - 32246. [Abstract] [Full Text] [PDF]

				C. Wasmeier and J. C. Hutton Secretagogue-dependent Phosphorylation of the Insulin Granule Membrane Protein Phogrin Is Mediated by cAMP-dependent Protein Kinase J. Biol. Chem., August 17, 2001; 276(34): 31919 - 31928. [Abstract] [Full Text] [PDF]